(Taken from the Application) The Pharmacological Sciences Training Program is designed to provide predoctoral students with a strong foundation in basic pharmacological principles and a broad knowledge of other related basic science disciplines, including biochemistry, medicinal chemistry, chemistry, physiology, and toxicology. All students will complete a core curriculum in the pharmacological sciences consisting of courses in pharmacology and biological chemistry, with other courses designed to fit the programmatic needs of individual students. Students may follow one of two general tracks with emphasis on biological or chemical research. In the Biology Track; a degree may be obtained in pharmacology, biological chemistry, pharmaceutics, physiology, or toxicology. In the Chemistry Track, a degree may be obtained in medicinal chemistry, chemistry, biological chemistry, pharmaceutics, or pharmaceutical chemistry. Areas of research concentration within the program include cardiovascular/renal pharmacology, neuropharmacology, xenobiotic metabolism, growth and metabolic regulation, receptor structure and function, synthesis and pharmacology of therapeutic and diagnostic agents, transport mechanisms, drug absorption, drug delivery, and pharmacokinetics. Students obtain laboratory experience in several types of pharmacological research and learn how to design experiments, evaluate experimental data, and use appropriate statistical methods: The training program includes formal, graduate-level courses with lectures, discussions, and examinations; seminar programs, both formal and informal; supervised laboratory investigation leading to an independent study which forms the basis for the student's doctoral dissertation; a preliminary examination, and a final oral examination, during which the trainee defends the dissertation before a doctoral committee. Support is requested for 16 trainees per year increasing to 20 by the fourth year. Applicants for the Ph.D. programs participating in this training program must have a bachelor's degree in chemistry, biology, or other related scientific field. Highly qualified students who have an interest in pharmacological sciences are selected from among the students enrolled in the participating departments or programs. Selection of students is based on undergraduate and graduate GPA, GRE scores, research experience, letters of recommendation, and personal interviews. Students enter the PSTP at the beginning of their second year of graduate school and are generally supported by the training grant for two years, after which time they are usually supported by research grants. Rigorous policies of admissions, course grades, qualifying examinations, laboratory experiences, and thesis work are enforced to maintain a high level of quality. All the resources of the participating departments are available to this training program.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007767-28
Application #
6908067
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Preusch, Peter C
Project Start
1978-07-01
Project End
2006-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
28
Fiscal Year
2005
Total Cost
$568,514
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Pharmacology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Hu, Yongjun; Epling, Daniel; Shi, Jian et al. (2018) Effect of biphenyl hydrolase-like (BPHL) gene disruption on the intestinal stability, permeability and absorption of valacyclovir in wildtype and Bphl knockout mice. Biochem Pharmacol 156:147-156
Kuai, Rui; Sun, Xiaoqi; Yuan, Wenmin et al. (2018) Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy. J Control Release 282:131-139
Livingston, Kathryn E; Mahoney, Jacob P; Manglik, Aashish et al. (2018) Measuring ligand efficacy at the mu-opioid receptor using a conformational biosensor. Elife 7:
Masureel, Matthieu; Zou, Yaozhong; Picard, Louis-Philippe et al. (2018) Structural insights into binding specificity, efficacy and bias of a ?2AR partial agonist. Nat Chem Biol 14:1059-1066
Sanchez, Jaquelyn N; Wang, Ton; Cohen, Mark S (2018) BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers. Drugs 78:549-566
Epling, Daniel; Hu, Yongjun; Smith, David E (2018) Evaluating the intestinal and oral absorption of the prodrug valacyclovir in wildtype and huPepT1 transgenic mice. Biochem Pharmacol 155:1-7
Drake, Lindsey R; Scott, Peter J H (2018) DARK Classics in Chemical Neuroscience: Cocaine. ACS Chem Neurosci 9:2358-2372
Lamberts, Jennifer T; Rosenthal, Lisa D; Jutkiewicz, Emily M et al. (2018) Role of the guanine nucleotide binding protein, G?o, in the development of morphine tolerance and dependence. Psychopharmacology (Berl) 235:71-82
Beyett, Tyler S; Gan, Xinmin; Reilly, Shannon M et al. (2018) Design, synthesis, and biological activity of substituted 2-amino-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid derivatives as inhibitors of the inflammatory kinases TBK1 and IKK? for the treatment of obesity. Bioorg Med Chem 26:5443-5461
Senese, Nicolas B; Oginsky, Max; Neubig, Richard R et al. (2018) Role of hippocampal 5-HT1A receptors in the antidepressant-like phenotype of mice expressing RGS-insensitive G?i2 protein. Neuropharmacology 141:296-304

Showing the most recent 10 out of 325 publications